|
EXOSC9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.538300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.258100E-02 |
| Normal-vs-Stage2 |
1.567220E-01 |
| Normal-vs-Stage3 |
4.491000E-01 |
| Normal-vs-Stage4 |
3.688400E-01 |
| Stage1-vs-Stage2 |
9.454600E-01 |
| Stage1-vs-Stage3 |
3.118800E-01 |
| Stage1-vs-Stage4 |
8.357200E-01 |
| Stage2-vs-Stage3 |
4.225400E-01 |
| Stage2-vs-Stage4 |
7.791800E-01 |
| Stage3-vs-Stage4 |
7.160200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.435000E-01 |
| Normal-vs-AfricanAmerican |
8.162900E-03 |
| Normal-vs-Asian |
6.200600E-01 |
| Caucasian-vs-AfricanAmerican |
4.620100E-02 |
| Caucasian-vs-Asian |
8.923800E-01 |
| AfricanAmerican-vs-Asian |
1.201180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.644240E-01 |
| Normal-vs-Female |
3.443800E-02 |
| Male-vs-Female |
1.313200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.821630E-01 |
| Normal-vs-Extreme_Weight |
9.700000E-02 |
| Normal-vs-Obese |
7.752500E-02 |
| Normal-vs-Extreme_Obese |
5.323000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.661600E-01 |
| Normal_Weight-vs-Obese |
7.420800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.647600E-01 |
| Extreme_Weight-vs-Obese |
9.719400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.348400E-01 |
| Obese-vs-Extreme_Obese |
9.424000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.041800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.362200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.735400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.026600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.879630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.572400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.737600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.908300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.791800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.098400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.759700E-02 |
| Normal-VS-Type2 PRCC |
4.825400E-01 |
| Normal-VS-KIRP CIMP |
1.544010E-01 |
| Normal-VS-Unclassified PRCC |
2.380400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.996520E-04 |
| Type1 PRCC-VS-KIRP CIMP |
9.742800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.689800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.358200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.564400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.500200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.597400E-01 |
| Normal-vs-N1 |
8.784400E-02 |
| Normal-vs-N2 |
8.960200E-01 |
| N0-vs-N1 |
1.116980E-01 |
| N0-vs-N2 |
9.955000E-01 |
| N1-vs-N2 |
4.464000E-01 |
|
|
